Cuauhtemoc Licona
Chief Scientific Officer SciTherm Therapeutics
Seminars
Thursday 16th July 2026
Leveraging In-Silico Designed Thermogenics to Activate Selective Lipid Degradation Pathways for Sustained Fat Loss
9:00 am
- Harnessing in-silico molecular design to engineer high-potency thermogenic candidates with superior target specificity, ensuring the activation of fat-burning pathways while avoiding the off-target cardiovascular effects common in historical thermogenic attempts
- Validating novel lipid-degradation variants through metagenomic adipocyte analysis and in-vitro lipolysis assays, providing a data-driven proof-of-concept for direct adipose tissue reduction independent of caloric intake
- Optimizing specificity for adipose tissue metabolism to inhibit lipid accumulation at the cellular level, delivering a durable metabolic solution that targets the root cause of obesity-related comorbidities
